home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Gene For Rare Vascular Disorder Identified

 
  February, 17 2004 9:54
your information resource in human molecular genetics
 
     
Researchers have identified a gene that helps to regulate blood vessel growth. Mutations in the gene may contribute to the rare vascular disorder Klippel-Trenaunay syndrome (KTS).

Patients with KTS have malformed blood vessels in the skin. The problems often occur in just one enlarged limb, and the condition's cause is unknown. In the 12 February 2004 issue of Nature (Vol. 427, No. 6975, pp. 640-645), Qing Wang and colleagues show that patients with the condition carry a mutated version of a gene called VG5Q. The gene is thought to control blood vessel growth.

The unusual means by which these scientists identified and evaluated VG5Q, using a combination of human genetics and functional assays, underscores the importance of using similar approaches to help identify other factors involved in angiogenesis, the formation of new blood vessels, say Diether Lambrechts and Peter Carmeliet in an accompanying News and Views article. "Such factors could include molecules that are clinically relevant, or potential drug targets," they add.

CONTACT:

Qing Wang
The Cleveland Clinic Foundation
Cleveland, OH
USA
Tel: +1 216 445 0570
E-mail: wangq2@ccf.org

Peter Carmeliet and Diether Lambrechts
University of Leuven, Belgium
Tel: +32 16 34 57 74 (PC)
E-mail: peter.carmeliet@med.kuleuven.ac.be

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.